The Development of the SARS-CoV-2 Epidemic in Different Regions of Siberia in the 2020-2022 Period.
COVID-19
SARS-CoV-2
Siberia
epidemiology
phylogenetics
recombinants
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
27 09 2023
27 09 2023
Historique:
received:
11
08
2023
revised:
08
09
2023
accepted:
15
09
2023
medline:
30
10
2023
pubmed:
28
10
2023
entrez:
28
10
2023
Statut:
epublish
Résumé
The comparison of the development of the SARS-CoV-2 epidemic in several neighboring regions can help researchers to assess the risks and develop more effective strategies and approaches in the field of preventive medicine. We analyzed the infection and mortality statistics for the 2020-2022 period in ten individual regions of the Siberian Federal District of Russia. We also sequenced complete genomes, which allowed us to analyze the genetic diversity of SARS-CoV-2 circulated in each of the ten regions and to build a phylogenetic dendrogram for the virus variants. The ParSeq v.1.0 software was developed to automate and speed up the processing and analysis of viral genomes. At the beginning of the pandemic, in the first two waves, the B.1.1 variant (20B) dominated in all regions of the Siberian Federal District. The third and fourth waves were caused by the Delta variant. Mortality during this period was at a maximum; the incidence was quite high, but the number of deposited genomes with GISAID during this period was extremely low. The maximum incidence was at the beginning of 2022, which corresponds to the arrival of the Omicron variant in the region. The BA.5.2 variant became the dominant one. In addition, by using NextClade, we identified three recombinants in the most densely populated areas.
Identifiants
pubmed: 37896792
pii: v15102014
doi: 10.3390/v15102014
pmc: PMC10612024
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
PLoS One. 2022 Aug 30;17(8):e0273820
pubmed: 36040921
Viruses. 2022 Sep 14;14(9):
pubmed: 36146842
Nat Commun. 2021 Jan 28;12(1):649
pubmed: 33510171
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Nat Rev Microbiol. 2021 Mar;19(3):141-154
pubmed: 33024307
Nat Rev Microbiol. 2023 Jun;21(6):361-379
pubmed: 37020110
J Med Virol. 2022 Aug;94(8):3506-3508
pubmed: 35419806
Emerg Infect Dis. 2022 Apr;28(4):751-758
pubmed: 35203112
Vopr Virusol. 2021 Sep 18;66(4):299-309
pubmed: 34545722
BMC Bioinformatics. 2009 Dec 15;10:421
pubmed: 20003500
J Med Virol. 2022 Jun;94(6):2376-2383
pubmed: 35118687
Infection. 2021 Apr;49(2):233-239
pubmed: 33034020
Viruses. 2022 Apr 29;14(5):
pubmed: 35632673
Viruses. 2021 Aug 19;13(8):
pubmed: 34452512
Mol Biol Evol. 2021 Jun 25;38(7):3022-3027
pubmed: 33892491
Int J Infect Dis. 2020 Oct;99:40-46
pubmed: 32721529
J Neuroimmune Pharmacol. 2020 Sep;15(3):359-386
pubmed: 32696264